TG Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF93.16 | Buy/Sell | CHF105.00 | 15.52% | 9 | CHF190.08B |
| SAN | Sanofi | Outperform |
16
|
90.80€ | Buy/Sell | 102.80€ | 20.59% | 9 | 113.51€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$42.34 | Buy/Sell | $58.15 | 27.54% | 10 | $85.83B |
| MRK | Merck KGaA | Outperform |
18
|
168.50€ | Buy/Sell | 190.06€ | 8.61% | 4 | 73.26€B |
| BIIB | Biogen | Outperform |
10
|
$225.21 | Buy/Sell | $299.62 | 29.66% | 13 | $32.79B |
| BAYN | Bayer | Hold |
5
|
28.40€ | Buy/Sell | 45.15€ | 5.63% | 4 | 27.90€B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.88 | Buy/Sell | $11.59 | 0.71% | 9 | $19.12B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.06k | Buy/Sell | kr2.71k | 27.98% | 14 | kr132.66B |
| ALKS | Alkermes | Outperform |
10
|
$24.21 | Buy/Sell | $33.27 | 32.18% | 3 | $4.11B |